MedicationUse2-v1.0(2017EN): verschil tussen versies

Huidige versie van 20 feb 2018 om 10:06

Inhoud

1 General information
2 Metadata
3 Revision History
4 Concept
5 Purpose
6 Information Model
7 Example Instances
8 Valuesets
- 8.1 MedicationUseStopTypeCodeList
- 8.2 ReasonForChangeOrDiscontinuationOfUseCodList
9 This information model in other releases
10 More on this information model
11 About this information

General information

Name: nl.zorg.MedicationUse2
Version: 1.0
HCIM Status:Final
Release: 2017
Release status: Prepublished
Release date: 04-09-2017

Back to HCIM list

Metadata

DCM::CoderList	Projectgroep Medicatieproces
DCM::ContactInformation.Address
DCM::ContactInformation.Name	*
DCM::ContactInformation.Telecom
DCM::ContentAuthorList	Projectgroep Medicatieproces
DCM::CreationDate	1-2-2017
DCM::DeprecatedDate
DCM::DescriptionLanguage	nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name	PM
DCM::EndorsingAuthority.Telecom
DCM::Id	2.16.840.1.113883.2.4.3.11.60.40.3.9.11
DCM::KeywordList	Medicatie, Gebruik
DCM::LifecycleStatus	Final
DCM::ModelerList	Architectuurgroep Registratie aan de Bron
DCM::Name	nl.zorg.MedicatieGebruik2
DCM::PublicationDate	04-09-2017
DCM::PublicationStatus	Prepublished
DCM::ReviewerList	Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
DCM::RevisionDate	04-09-2017
DCM::Superseeds	nl.zorg.MedicatieGebruik-v3.0
DCM::Version	1.0
HCIM::PublicationLanguage	EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (04-09-2017).

Concept

MedicationUse is a statement on the historic, current or intended use of a certain medicine.

Purpose

The goal of the medication use is to provide insight into the patient’s pattern of use.

Information Model

Type

Id

Concept

Card.

Definition

DefinitionCode

Reference

NL-CM:9.11.21338

MedicationUse

Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.

NL-CM:9.11.23290

Prescriber::HealthProfessional

0..1

The health professional that entered the medication agreement with the patient.

HealthProfessional

NL-CM:9.11.21339

ProductUsed::Product

1

The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.

In principle, this will be the prescribed product, but the product used may differ from the prescribed product.

Product

NL-CM:9.11.22504

InstructionsForUse

0..1

Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed.

InstructionsForUse

NL-CM:9.11.22398

MedicationUseDateTime

1

Date on which this use is entered.

NL-CM:9.11.22663

PeriodOfUse

0..1

Start date: This is the time at which the agreement was to take effect (or took effect or will take effect).

Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days. End date: The time at which the period of use ends (or ended or will end). To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.

TimeInterval

NL-CM:9.11.22492

AsAgreedIndicator

0..1

Is the medicine used as outlined in the medication agreement?

NL-CM:9.11.22399

UseIndicator

1

Is this medicine used or not?

NL-CM:9.11.22491

ReasonForUse

0..1

The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.

NL-CM:9.11.23132

MedicationUseStopType

0..1

Stop type, the manner in which this medication is discontinued (temporary or definitive).

MedicationUseStopTypeCodeList

NL-CM:9.11.22493

ReasonForChangeOrDiscontinuationOfUse

0..*

Reason for changing or discontinuing use of medication.

ReasonForChangeOrDiscontinuationOfUseCodList

NL-CM:9.11.21624

Comment

0..1

Comments on the medication use.

48767-8 Annotation comment

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page

Example Instances

Only available in Dutch

MedicatieGebruik DatumTijd	GebruikIndicator	VolgensAfspraak Indicator	Medicatiegebruik Stoptype	Gebruiksperiode			Gebruiksproduct
				Ingangsdatum	Einddatum	Gebruiksduur	ProductCode

3-6-2014 16:19:07	Ja			Mei 2014		1 maand	Paracetamol tablet 500 mg
11-9-2012 17:21:00	Ja	Ja		01-09-12	05-09-12		Pantoprazol injpdr 40 mg fl
19-9-2014 4:12:11	Nee	Nee	Definitief	17-09-14			Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml

RedenGebruik	RedenWijzigen OfStoppen Gebruik	GebruiksInstructie
		Omschrijving	ToedieningsWeg	Aanvullende instructie	Doseerinstructie
					Doseerduur	Dosering\| Keerdosis	Toedieningsschema \|Frequentie \|Interval \|Toedientijd \|Weekdag \|Dagdeel
Pijn		In de maand mei heb ik regelmatig paracetamol gebruikt.
Ulcusprofylaxe		Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)	iv			40 mg (=1 st)	1x per dag om 8.00 uur
	(Mogelijke) bijwerking	Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.	subcutaan			2500 IE	1x per dag om 18.00 uur

Valuesets

MedicationUseStopTypeCodeList

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Tijdelijk	1	Medicatieafspraak StopType	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1	Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
Definitief	2	Medicatie afspraak StopType	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1	Het staken van een bestaande medicamenteuze behandeling.

ReasonForChangeOrDiscontinuationOfUseCodList

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Medication commenced (finding)	266709005	SNOMED CT	2.16.840.1.113883.6.96	Starten medicamenteuze behandeling
Administration of drug or medicament contraindicated (situation)	438833006	SNOMED CT	2.16.840.1.113883.6.96	Contra-indicatie
Drug interaction (disorder)	79899007	SNOMED CT	2.16.840.1.113883.6.96	Interactie
Hypersensitivity condition (disorder)	473010000	SNOMED CT	2.16.840.1.113883.6.96	Overgevoeligheid
Geen of onvoldoende effect	5	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Geen of onvoldoende effect
Te sterk effect	6	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Te sterk effect
(Mogelijke) bijwerking	7	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	(Mogelijke) bijwerking
Toedieningsweg voldoet niet	8	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Toedieningsweg voldoet niet
Indicatie vervallen	9	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Indicatie vervallen
Beleidswijziging	10	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Beleidswijziging
Admission to establishment (procedure)	305335007	SNOMED CT	2.16.840.1.113883.6.96	Opname
Wens patiënt	12	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Wens patiënt
Volgens afspraak	13	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Volgens afspraak
Hervatten beleid vorige voorschrijver	14	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Hervatten beleid vorige voorschrijver
Geplande procedure	15	Medicatieafspraak Reden	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2	Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc.
Overig	OTH	NullFlavour	2.16.840.1.113883.5.1008	Overig

This information model in other releases

---

More on this information model

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR

This information model is also available as pdf file or as spreadsheet

About this information

The information in this wikipage is based on Prerelease 2017 #1
Conditions for use are located on the mainpage
This page is generated on 30/11/2017 13:37:32

Back to HCIM list

MedicationUse2-v1.0(2017EN): verschil tussen versies

Huidige versie van 20 feb 2018 om 10:06

Inhoud

General information

Metadata

Revision History

Concept

Purpose

Information Model

Example Instances

Valuesets

MedicationUseStopTypeCodeList

ReasonForChangeOrDiscontinuationOfUseCodList

This information model in other releases

More on this information model

About this information

Navigatiemenu

Persoonlijke instellingen

Naamruimten

Varianten

Weergaven

Meer

Zoeken

Navigatie

Zorginformatiebouwsteen

Hulpmiddelen

@@ Regel 3: / Regel 3: @@
 Version: '''1.0''' <br>
 HCIM Status:Final<br>
-Publication: '''2017''' <br>
+Release: '''2017''' <br>
 Release status: Prepublished<br>
-Publication date: 04-09-2017
+Release date: 04-09-2017
 -----
 <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
@@ Regel 74: / Regel 74: @@
 ==Information Model==
 <BR>
-[[Bestand: MedicationUse2-v1.0Model(EN).png | center]]
+<imagemap> Bestand:MedicationUse2-v1.0Model(EN).png | center
+rect 179 91 291 155 [[HealthProfessional-v3.1(2017EN)]]
+rect 496 480 731 540 [[#ReasonForChangeOrDiscontinuationOfUseCodList]]
+rect 762 480 962 540 [[#MedicationUseStopTypeCodeList]]
+rect 745 373 887 443 [[#13447]]
+rect 629 91 741 161 [[#13449]]
+rect 479 91 591 155 [[InstructionsForUse-v1.0(2017EN)]]
+rect 775 236 886 300 [[#13450]]
+rect 329 91 441 155 [[Product-v1.0(2017EN)]]
+rect 774 93 886 163 [[#13455]]
+rect 170 229 312 299 [[#13448]]
+rect 513 374 684 444 [[#13445]]
+rect 333 374 475 444 [[TimeInterval-v1.0(2017EN)]]
+rect 166 373 308 443 [[#13451]]
+rect 488 229 599 299 [[#13453]]
+desc none
+</imagemap>
 <BR>
 {| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
@@ Regel 80: / Regel 96: @@
 |style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
 |-style="vertical-align:top; background-color: #E3E3E3; "
-|style = "text-align:center" |[[Bestand: block.png| 20px]]
+|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
 ||NL-CM:9.11.21338
-|colspan ="6" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px]]MedicationUse</span>
+|colspan ="6" style ="padding-left: 0px"|<span Id=13453 Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px | link=]]MedicationUse</span>
 |
 |Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
@@ Regel 88: / Regel 104: @@
 |
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
+|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
 ||NL-CM:9.11.23290
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Voorschrijver::Zorgverlener">[[Bestand: arrowright.png | 10px]]Prescriber::HealthProfessional</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13452 Title="NL: Voorschrijver::Zorgverlener">[[Bestand: arrowright.png | 10px | link=]]Prescriber::HealthProfessional</span>
 |0..1
 |The health professional that entered the medication agreement with the patient.
@@ Regel 98: / Regel 114: @@
 {|
 |-
-|[[Bestand: block.png]]||[[HealthProfessional-v3.1(2017EN) |HealthProfessional]]
+|[[Bestand: block.png | link=HealthProfessional-v3.1(2017EN)]]||[[HealthProfessional-v3.1(2017EN) |HealthProfessional]]
 |}
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
+|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
 ||NL-CM:9.11.21339
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksproduct::Product">[[Bestand: arrowright.png | 10px]]ProductUsed::Product</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13454 Title="NL: Gebruiksproduct::Product">[[Bestand: arrowright.png | 10px | link=]]ProductUsed::Product</span>
 |1
 |The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.
@@ Regel 113: / Regel 129: @@
 {|
 |-
-|[[Bestand: block.png]]||[[Product-v1.0(2017EN) |Product]]
+|[[Bestand: block.png | link=Product-v1.0(2017EN)]]||[[Product-v1.0(2017EN) |Product]]
 |}
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
+|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
 ||NL-CM:9.11.22504
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksinstructie">[[Bestand: arrowright.png | 10px]]InstructionsForUse</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13457 Title="NL: Gebruiksinstructie">[[Bestand: arrowright.png | 10px | link=]]InstructionsForUse</span>
 |0..1
 |Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed.
@@ Regel 126: / Regel 142: @@
 {|
 |-
-|[[Bestand: block.png]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]]
+|[[Bestand: block.png | link=InstructionsForUse-v1.0(2017EN)]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]]
 |}
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: TS.png| 16px]]
+|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
 ||NL-CM:9.11.22398
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikDatumTijd">[[Bestand: arrowright.png | 10px]]MedicationUseDateTime</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13451 Title="NL: MedicatieGebruikDatumTijd">[[Bestand: arrowright.png | 10px | link=]]MedicationUseDateTime</span>
 |1
 |Date on which this use is entered.
@@ Regel 138: / Regel 154: @@
 |
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
+|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
 ||NL-CM:9.11.22663
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksperiode::TijdsInterval">[[Bestand: arrowright.png | 10px]]PeriodOfUse</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13456 Title="NL: Gebruiksperiode::TijdsInterval">[[Bestand: arrowright.png | 10px | link=]]PeriodOfUse</span>
 |0..1
 |<b>Start date</b>: This is the time at which the agreement was to take effect (or took effect or will take effect).
@@ Regel 150: / Regel 166: @@
 {|
 |-
-|[[Bestand: block.png]]||[[Zib of versie niet gevonden-v??(2017EN) |Zib of versie niet gevonden]]
+|[[Bestand: block.png | link=TimeInterval-v1.0(2017EN)]]||[[TimeInterval-v1.0(2017EN) |TimeInterval]]
 |}
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: BL.png| 16px]]
+|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
 ||NL-CM:9.11.22492
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: VolgensAfspraakIndicator">[[Bestand: arrowright.png | 10px]]AsAgreedIndicator</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13448 Title="NL: VolgensAfspraakIndicator">[[Bestand: arrowright.png | 10px | link=]]AsAgreedIndicator</span>
 |0..1
 |Is the medicine used as outlined in the medication agreement?
@@ Regel 162: / Regel 178: @@
 |
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: BL.png| 16px]]
+|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
 ||NL-CM:9.11.22399
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: GebruikIndicator">[[Bestand: arrowright.png | 10px]]UseIndicator</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13455 Title="NL: GebruikIndicator">[[Bestand: arrowright.png | 10px | link=]]UseIndicator</span>
 |1
 |Is this medicine used or not?
@@ Regel 171: / Regel 187: @@
 |
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: ST.png| 16px]]
+|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
 ||NL-CM:9.11.22491
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: RedenGebruik">[[Bestand: arrowright.png | 10px]]ReasonForUse</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13449 Title="NL: RedenGebruik">[[Bestand: arrowright.png | 10px | link=]]ReasonForUse</span>
 |0..1
 |The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.
@@ Regel 180: / Regel 196: @@
 |
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: CD.png| 16px]]
+|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
 ||NL-CM:9.11.23132
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikStopType">[[Bestand: arrowright.png | 10px]]MedicationUseStopType</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13447 Title="NL: MedicatieGebruikStopType">[[Bestand: arrowright.png | 10px | link=]]MedicationUseStopType</span>
 |0..1
 |Stop type, the manner in which this medication is discontinued (temporary or definitive).
@@ Regel 190: / Regel 206: @@
 {|
 |-
-|[[Bestand: List2.png]]||[[#MedicationUseStopTypeCodeList|MedicationUseStopTypeCodeList]]
+|[[Bestand: List2.png | link=#MedicationUseStopTypeCodeList]]||[[#MedicationUseStopTypeCodeList|MedicationUseStopTypeCodeList]]
 |}
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: CD.png| 16px]]
+|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
 ||NL-CM:9.11.22493
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: RedenWijzigenOfStoppenGebruik">[[Bestand: arrowright.png | 10px]]ReasonForChangeOrDiscontinuationOfUse</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13445 Title="NL: RedenWijzigenOfStoppenGebruik">[[Bestand: arrowright.png | 10px | link=]]ReasonForChangeOrDiscontinuationOfUse</span>
 |0..*
 |Reason for changing or discontinuing use of medication.
@@ Regel 203: / Regel 219: @@
 {|
 |-
-|[[Bestand: List2.png]]||[[#ReasonForChangeOrDiscontinuationOfUseCodList|ReasonForChangeOrDiscontinuationOfUseCodList]]
+|[[Bestand: List2.png | link=#ReasonForChangeOrDiscontinuationOfUseCodList]]||[[#ReasonForChangeOrDiscontinuationOfUseCodList|ReasonForChangeOrDiscontinuationOfUseCodList]]
 |}
 |-style="vertical-align:top; background-color: transparent; "
-|style = "text-align:center" |[[Bestand: ST.png| 16px]]
+|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
 ||NL-CM:9.11.21624
 |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
-|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toelichting">[[Bestand: arrowright.png | 10px]]Comment</span>
+|colspan ="5" style ="padding-left: 0px"|<span Id=13450 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Comment</span>
 |0..1
 |Comments on the medication use.
@@ Regel 227: / Regel 243: @@
 {|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
 |-style=vertical-align:top;
-| style="background-color: #1F497D; width: 18%; color: #FFFFFF; font-weight: bold; "|MedicatieGebruik DatumTijd
+| style="background-color: #1F497D; width: 18%; "|<font color=#FFFFFF><b>MedicatieGebruik</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>DatumTijd</b></font>
-| style="background-color: #1F497D; width: 4%; color: #FFFFFF; font-weight: bold; "|GebruikIndicator
+| style="background-color: #1F497D; width: 4%; "|<font color=#FFFFFF><b>GebruikIndicator</b></font>
-| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|VolgensAfspraak Indicator
+| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>VolgensAfspraak</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>Indicator</b></font>
-| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|Medicatiegebruik Stoptype
+| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>Medicatiegebruik</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>Stoptype</b></font>
-|colspan="3" style="background-color: #1F497D; width: 27%; color: #FFFFFF; font-weight: bold; "|Gebruiksperiode
+|colspan="3" style="background-color: #1F497D; width: 27%; "|<font color=#FFFFFF><b>Gebruiksperiode</b></font>
-| style="background-color: #1F497D; width: 28%; color: #FFFFFF; font-weight: bold; "|Gebruiksproduct
+| style="background-color: #1F497D; width: 28%; "|<font color=#FFFFFF><b>Gebruiksproduct</b></font>
 |-style=vertical-align:top;
 | style="background-color: #548DD4; width: 18%; "|
@@ Regel 238: / Regel 254: @@
 | style="background-color: #548DD4; width: 11%; "|
 | style="background-color: #548DD4; width: 11%; "|
-| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|Ingangsdatum
+| style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>Ingangsdatum</b></font>
-| style="background-color: #548DD4; width: 8%; color: #FFFFFF; font-weight: bold; "|Einddatum
+| style="background-color: #548DD4; width: 8%; "|<font color=#FFFFFF><b>Einddatum</b></font>
-| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|Gebruiksduur
+| style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>Gebruiksduur</b></font>
-| style="background-color: #548DD4; width: 28%; color: #FFFFFF; font-weight: bold; "|ProductCode
+| style="background-color: #548DD4; width: 28%; "|<font color=#FFFFFF><b>ProductCode</b></font>
 |-style=vertical-align:top;
 | style="background-color: #D9D9D9; width: 18%; "|
@@ Regel 252: / Regel 268: @@
 | style="background-color: #D9D9D9; width: 28%; "|
 |-style=vertical-align:top;
-| style="width: 18%; color: #000000; "|3-6-2014 16:19:07
+| style="width: 18%; "|3-6-2014 16:19:07
 | style="width: 4%; "|Ja
 | style="width: 11%; "|
@@ Regel 259: / Regel 275: @@
 | style="width: 8%; "|
 | style="width: 9%; "|1 maand
-| style="width: 28%; color: #000000; "|Paracetamol tablet 500 mg
+| style="width: 28%; "|Paracetamol tablet 500 mg
 |-style=vertical-align:top;
-| style="width: 18%; color: #000000; "|11-9-2012 17:21:00
+| style="width: 18%; "|11-9-2012 17:21:00
 | style="width: 4%; "|Ja
 | style="width: 11%; "|Ja
 | style="width: 11%; "|
 | style="width: 9%; "|01-09-12
-| style="width: 8%; color: #000000; "|05-09-12
+| style="width: 8%; "|05-09-12
 | style="width: 9%; "|
-| style="width: 28%; color: #000000; "|Pantoprazol injpdr 40 mg fl
+| style="width: 28%; "|Pantoprazol injpdr 40 mg fl
 |-style=vertical-align:top;
-| style="width: 18%; color: #000000; "|19-9-2014 4:12:11
+| style="width: 18%; "|19-9-2014 4:12:11
 | style="width: 4%; "|Nee
 | style="width: 11%; "|Nee
 | style="width: 11%; "|Definitief
-| style="width: 9%; color: #000000; "|17-09-14
+| style="width: 9%; "|17-09-14
 | style="width: 8%; "|
 | style="width: 9%; "|
-| style="width: 28%; color: #000000; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
+| style="width: 28%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
 |}
 {|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
 |-style=vertical-align:top;
-| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|RedenGebruik
+| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>RedenGebruik</b></font>
-| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|RedenWijzigen OfStoppen Gebruik
+| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>RedenWijzigen</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>OfStoppen</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>Gebruik</b></font>
-|colspan="5" style="background-color: #1F497D; width: 59%; color: #FFFFFF; font-weight: bold; "|GebruiksInstructie
+|colspan="5" style="background-color: #1F497D; width: 59%; "|<font color=#FFFFFF><b>GebruiksInstructie</b></font>
 | style="background-color: #1F497D; width: 19%; "|
 |-style=vertical-align:top;
 | style="background-color: #548DD4; width: 11%; "|
 | style="background-color: #548DD4; width: 11%; "|
-| style="background-color: #548DD4; width: 16%; color: #FFFFFF; font-weight: bold; "|Omschrijving
+| style="background-color: #548DD4; width: 16%; "|<font color=#FFFFFF><b>Omschrijving</b></font>
-| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|ToedieningsWeg
+| style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font>
-| style="background-color: #548DD4; width: 11%; color: #FFFFFF; font-weight: bold; "|Aanvullende instructie
+| style="background-color: #548DD4; width: 11%; "|<font color=#FFFFFF><b>Aanvullende instructie</b></font>
-| style="background-color: #548DD4; width: 11%; color: #FFFFFF; font-weight: bold; "|Doseerinstructie
+| style="background-color: #548DD4; width: 11%; "|<font color=#FFFFFF><b>Doseerinstructie</b></font>
 | style="background-color: #548DD4; width: 12%; "|
 | style="background-color: #548DD4; width: 19%; "|
@@ Regel 300: / Regel 316: @@
 | style="background-color: #D9D9D9; width: 9%; "|
 | style="background-color: #D9D9D9; width: 11%; "|
-| style="background-color: #D9D9D9; width: 11%; color: Black; font-weight: bold; "|Doseerduur
+| style="background-color: #D9D9D9; width: 11%; "|<b>Doseerduur</b>
-| style="background-color: #D9D9D9; width: 12%; color: Black; font-weight: bold; "|Dosering<noWiki>|</noWiki> Keerdosis
+| style="background-color: #D9D9D9; width: 12%; "|<b>Dosering<noWiki>|</noWiki></b><b> </b><b>Keerdosis</b>
-| style="background-color: #D9D9D9; width: 19%; color: #000000; font-weight: bold; "|Toedieningsschema <noWiki>|</noWiki>Frequentie <noWiki>|</noWiki>Interval <noWiki>|</noWiki>Toedientijd <noWiki>|</noWiki>Weekdag <noWiki>|</noWiki>Dagdeel<BR>
+| style="background-color: #D9D9D9; width: 19%; "|<b>Toedieningsschema</b><b> </b><b><noWiki>|</noWiki>Frequentie</b><b> </b><b><noWiki>|</noWiki>Interval</b><b> </b><b><noWiki>|</noWiki>Toedientijd</b><b> </b><b><noWiki>|</noWiki>Weekdag</b><b> </b><b><noWiki>|</noWiki>Dagdeel</b><BR>
 |-style=vertical-align:top;
 | style="width: 11%; "|Pijn
 | style="width: 11%; "|
-| style="width: 16%; color: #000000; "|In de maand mei heb ik regelmatig paracetamol gebruikt.
+| style="width: 16%; "|In de maand mei heb ik regelmatig paracetamol gebruikt.
 | style="width: 9%; "|
 | style="width: 11%; "|
@@ Regel 315: / Regel 331: @@
 | style="width: 11%; "|Ulcusprofylaxe
 | style="width: 11%; "|
-| style="width: 16%; color: #000000; "|Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)
+| style="width: 16%; "|Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)
 | style="width: 9%; "|iv
 | style="width: 11%; "|
 | style="width: 11%; "|
-| style="width: 12%; color: #000000; "|40 mg (=1 st)
+| style="width: 12%; "|40 mg (=1 st)
 | style="width: 19%; "|1x per dag om 8.00 uur
 |-style=vertical-align:top;
 | style="width: 11%; "|
-| style="width: 11%; color: #000000; "|(Mogelijke) bijwerking
+| style="width: 11%; "|(Mogelijke) bijwerking
-| style="width: 16%; color: #000000; "|Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.
+| style="width: 16%; "|Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.
 | style="width: 9%; "|subcutaan
 | style="width: 11%; "|
 | style="width: 11%; "|
-| style="width: 12%; color: #000000; "|2500 IE
+| style="width: 12%; "|2500 IE
-| style="width: 19%; color: #000000; "|1x per dag om 18.00 uur<BR>
+| style="width: 19%; "|1x per dag om 18.00 uur<BR>
 |}
@@ Regel 468: / Regel 484: @@
+==This information model in other releases==
+---
 ==More on this information model==
-More technical information and HL7/XML documentation you can find on the Nictiz Art-Decor page about this information model[http://decor.nictiz.nl/art-decor/decor-datasets--zib1bbr-?id=2.16.840.1.113883.2.4.3.11.60.40.3.9.11] <BR>
+To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
-This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0(EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0(EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
+Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
+<ul>
+<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.11&effectiveDate=2017-09-04T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
+<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=Profile [[File:fhir.png|link=]]]</li>
+</ul>
+This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
 ==About this information==
 The information in this wikipage is based on Prerelease 2017 #1 <BR>
 Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
-This page is generated on 21/09/2017 13:51:20 <BR>
+This page is generated on 30/11/2017 13:37:32 <BR>
 -----
 <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>